BD Diagnostic Solutions / Becton, Dickinson & Company
Explore this company’s associated devices, FDA decisions and regulatory history.

BD Diagnostic Solutions / Becton, Dickinson & Company
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name BD Diagnostic Solutions / Becton, Dickinson & Company. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 27, 2026 to Oct 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QVF appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 7 Loveton Cir., Sparks, MD, 21152, US. Recorded on K261379, decision dated Oct 27, 2026.
Device categories in this collection
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| BD Diagnostic Solutions / Becton, Dickinson & Company | 510(k) clearance | Oct 27, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
